[化疗引起的恶心和吐]
1Med. Klinik IV, Hämatologie-Onkologie/Palliativmedizin, Klinikum Neuperlach, Oskar-Maria-Graf-Ring 51, 81737, München, Deutschland. meinolf.karthaus@muenchen-klinik.de.
HNO
|June 2, 2023
概括
化疗引起的恶心和吐 (CINV) 显著影响癌症患者.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗引起的恶心和吐 (CINV) 是癌症治疗的显著不良影响.
- CINV对患者的生活质量产生负面影响,可能导致住院治疗,并危及治疗的继续.
- 预期的恶心和吐可能会使CINV管理和进一步的化疗复杂化.
研究的目的:
- 审查目前CINV预防的现状.
- 强调遵守指导方针对于有效的CINV管理的重要性.
主要方法:
- 对CINV预防的既定指南的审查.
- 对药理干预对CINV结果的影响分析.
主要成果:
- 自20世纪90年代以来,CINV预防方面取得了显著的改进.
- 高剂量的甲和受体对抗剂 (5-HT3,NK1) 是现代CINV管理的关键组成部分.
- 遵守既定的指导方针与改善患者的治疗结果有关.
结论:
- 目前的CINV预防策略,以既定建议为指导,已经大大改善了患者的护理.
- 基于指南的预防方法的一致应用对于减轻CINV的负担和确保治疗的连续性至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
256
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
256
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
210
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
210
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
359
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
359
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
328
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
328
Pathophysiology of Vomiting
680
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
680
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


